STK38 and prostate cancer: To test whether NDR1 could play a role as a metastasis suppressor in prostate cancer cell, NDR1 was knockdown in 2 cell lines (PC3 and LNCaP) (Figure 3A), which have weaken metastatic ability and expressed NDR1 at high level compared with the other 2 cell lines.